Научные статьи \ Прикладные науки. Медицина. Технология \ Mедицинские науки \ Патология. Клиническая медицина \ Заболевания кроветворной системы, лимфатической системы и желез внутренней секреции. Эндокринные заболевания

Место и роль резекции в хирургическом лечении локализованного рака предстательной железы

Место и роль резекции в хирургическом лечении локализованного рака предстательной железы

Автор: Попов С.В., Орлов И.Н., Малевич Сергей Михайлович, Сушина И.В., Гринь Е.А., Гулько А.М., Топузов Т.М., Вязовцев П.В.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Онкоурология

Статья в выпуске: 3, 2020 года.

Бесплатный доступ

Введение. Рак предстательной железы на сегодняшний день является одной из главных проблем в онкоурологии. Благодаря стремительным темпам роста индустрии здравоохранения возрастает качество оказания медицинской помощи. При этом повышается процент выявления рака предстательной железы в отношении локализованных форм. Последние достижения магнитно-резонансной томографии позволяют определять очаги подозрительные на опухоль в различных анатомических областях предстательной железы. Работы последних лет описывают, так называемую, резекцию предстательной железы при «переднем» раке как альтернативу стандартному лечению. Целью данной работы явилась оценка роли резекции предстательной железы в онкоурологической клинической практике. Материалы и методы. Проанализировано 59 публикаций, посвященных вопросам лечения локализованного рака предстательной железы. Результаты. Изложенные в исследовании малоинвазивные методики по мнению авторов показывают высокую эффективность в сохранении эректильной функции и удержания мочи при хирургическом лечении локализованной формы рака предстательной железы. Учитывая результаты, подобные оперативные вмешательства могут быть альтернативной тактикой между активным наблюдением и радикальной про-статэктомией у пациентов с локализованным раком предстательной железы. Заключение. Данные методики являются альтернативными и предполагают дальнейшее определение показаний для их выполнения. Однако, для этого требуется проведения большего количества исследований и оптимизации визуализационных методов диагностики рака простаты.

Еще

Рак предстательной железы, лечение, резекция предстательной железы

Короткий адрес: https://sciup.org/142225699

IDR: 142225699   |   DOI: 10.29188/2222-8543-2020-12-3-50-57

The place and role of resection in the surgical treatment of localized prostate cancer

Introduction. Currently, prostate cancer is one of the main problems in oncourology. The development of the health-care industry has increased the quality of treatment. This increases the percentage of detection of localized forms of prostate cancer. Recent advances in MR-tomography does possible detection of tumor-suspicious focuses in various anatomical areas of the prostate. The studies of recent years describe prostate resection in anterior cancer as an alternative to standard treatment. Aim. The aim of this study was to evaluate the role of prostate resection in oncological clinical practice. Materials and methods. 59 publications on the treatment of localized prostate cancer were analysed. Results. The minimally invasive techniques described in the study, according to the authors, show high efficiency in preserving erectile function and urinary retention in the surgical treatment of localized prostate cancer. Given the results, such surgical interventions may be an alternative tactic between active surveillance and radical prostatectomy in patients with localized prostate cancer. Conclusion. These techniques are alternative and involve further determination of the indications for their implementation. However, this requires more research and optimization of imaging methods for diagnosing prostate cancer.

Еще

Список литературы Место и роль резекции в хирургическом лечении локализованного рака предстательной железы

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018. DOI: 10.3322/caac.21492
  • Arkhipova О, Chernogubova Е. Analysis of the incidence of prostate cancer in the Rostov region for the years 2001-2016: spatiotemporal Statistics. Herald Urology 2017; 5(4):13-21. DOI: 10.21886/2308-6424-2017-5-4-13-21
  • SEER Cancer Statistics Review 1975-2016 [Internet]. [cited 2020 Mar 12]. Available from: https://seer.cancer.gov/csr/1975_2016/browse_csr.php?sectionSEL=23&page-SEL=sect_23_table.10
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019. DOI: 10.3322/caac.21551
  • Collin SM, Martin RM, Metcalfe C, Gunnell D, Albertsen PC, Neal D, et al. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 2008; 9(5):445-52. DOI: 10.1016/S1470-2045(08)70104-9
  • Eggener S, Salomon G, Scardino PT, De la Rosette J, Polascik TJ, Brewster S. Focal Therapy for Prostate Cancer: Possibilities and Limitations. Eur Urol 2010; 58; 5764
  • DOI: 10.1016/j.eururo.2010.03.034
  • Delongchamps NB, Singh A, Haas GP. The role of prevalence in the diagnosis of prostate cancer. Cancer Control 2006; 13(3):158-168
  • DOI: 10.1177/107327480601300302
  • Bell KJ, Del Mar C, Wright G, Dickinson J, Glasziou P. Prevalence of incidental prostate cancer: A systematic review of autopsy studies. Int J Cancer 2015; 137(7):1749-1757
  • DOI: 10.1002/ijc.29538
  • Mouraviev V, Mayes JM, Polascik TJ. Pathologic basis of focal therapy for early-stage prostate cancer. Nat Rev Urol 2009.6(4):205-215
  • DOI: 10.1038/nrurol.2009.29
  • Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V. Pathologic stage T2a and T2b Prostate cancer in the recent Prostate-specific antigen era: Implications for unilateral ablative therapy. Prostate 2008.68(13):1380-1386
  • DOI: 10.1002/pros.20804
  • Bott SR, Young MPA, Kellett MJ, Parkinson MC. Anterior prostate cancer: Is it more difficult to diagnose? BJU Int 2002;89(9):886-9.
  • DOI: 10.1046/j.1464-410x.2002.02796
  • Ouzzane A, Puech P, Lemaitre L, Leroy X, Nevoux P, Betrouni N, et al. Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. Urology 2011;78(6):1356-1362
  • DOI: 10.1016/j.urol-ogy.2011.06.022
  • Bouye S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A. Transition zone and anterior stromal Prostate cancers: Zone of origin and intraprostatic patterns of spread at histopathology. Prostate 2009;69(1):105-113
  • DOI: 10.1002/pros.20859
  • Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, et al. Natural history of early, localized prostate cancer. J Am Med Assoc 2004;291(22):2713
  • DOI: 10.1001/jama.291.22.2713
  • Barocas DA, Alvarez JA, Resnick MJ, Koyama T, Hoffman KE, Tyson MD, et al. Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years. JAMA 2017; 317(11):1126
  • DOI: 10.1001/jama.2017.1704
  • Prostate Cancer [Internet]. [cited 2020 Mar 12]. Available from: https://www.nccn.org/patients/guidelines/content/PDF/prostate-patient.pdf
  • Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014;370(10):932-942
  • DOI: 10.1056/NEJMoa1311593
  • Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. In: J Urol 1999;162(2):433-438 PMID: 10411052.
  • Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367(3):203-213
  • DOI: 10.1056/NEJMoa1113162
  • Bekelman JE, Rumble RB, Chen RC, Pisansky TM, Finelli A, Feifer A, et al. Clinically localized prostate cancer: ASCO clinical practice guideline endorsement of an American Urological Association/American Society for Radiation Oncology/ Society of Urologic Oncology Guideline. J Clin Oncol 2018; 36(32):3251-3258. DOI: 10;1200/JCO.18.00606.
  • Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, et al. Prediction of erectile function following treatment for prostate cancer. JAMA 2011;306(11):1205
  • DOI: 10.1001/jama.2011.1333
  • Kundu SD, Roehl KA, Eggener SE, Antenor JA V., Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004;172(6):2227-2231
  • DOI: 10.1097/01.ju.0000145222.94455.73
  • Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, et al. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options. J Urol 2018;199(4):990-997
  • DOI: 10.1016/j.juro.2018.01.002
  • Chen RC, Basak R, Meyer AM, Kuo TM, Carpenter WR, Agans RP, et al. Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA - J Am Med Assoc 2017;377(11): 1141
  • DOI: 10.1001/jama.2017.1652
  • Tyson MD, Koyama T, Lee D, Hoffman KE, Resnick MJ, Wu XC, et al. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results. Eur Urol 2018;74(1):26-33
  • DOI: 10.1016/j.eururo.2018.02.012
  • Sivarajan G, Prabhu V, Taksler GB, Laze J, Lepor H. Ten-year outcomes of sexual function after radical prostatectomy: Results of a prospective longitudinal study. Eur Urol 2014;65(1):58-65
  • DOI: 10.1016/j.eururo.2013.08.019
  • Lee JK, Assel M, Thong AE, Sjoberg DD, Mulhall JP, Sandhu J, et al. Unexpected long-term improvements in urinary and erectile function in a large cohort of men with self-reported outcomes following radical prostatectomy. Eur Urol 2015.68(5):899-905
  • DOI: 10.1016/j.eururo.2015.07.074
  • Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. Engl J Med 2008;358(12):1250-61.
  • DOI: 10.1056/NEJMoa074311
  • Martis G, Diana M, Ombres M, Cardi A, Mastrangeli R, Mastrangeli B. Retropubic versus perineal radical prostatectomy in early prostate cancer: Eight-year experience. J Surg Oncol 2007;95(6):513-518
  • DOI: 10.1002/jso.20714
  • Lance RS, Freidrichs PA, Kane C, Powell CR, Pulos E, Moul JW, et al. A comparison of radical retropubic with perineal prostatectomy for localized prostate cancer within the Uniformed Services Urology Research Group. BJU Int 2001;87(1):61-65
  • DOI: 10.1046/j.1464-410x.2001.00023.x
  • Ramirez D, Maurice MJ, Kaouk JH. Robotic perineal radical prostatectomy and pelvic lymph node dissection using a purpose-built single-port robotic platform. BJU Int 2016;118(5):829-833
  • DOI: 10.1111/bju.13581
  • Kaouk JH, Akca O, Zargar H, Caputo P, Ramirez D, Andrade H, et al. Descriptive Technique and Initial Results for Robotic Radical Perineal Prostatectomy. Urology 2016;94:129-138
  • DOI: 10.1016/j.urology.2016.02.063
  • Mayes JM, Mouraviev V, Sun L, Tsivian M, Madden JF, Polascik TJ. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol Semin OrigInvestig2011;29(2):166-170
  • DOI: 10.1016/j.urolonc.2009.03.011
  • Tsivian M, Kimura M, Sun L, Mouraviev V, Mayes JM, Polascik TJ. Predicting unilateral prostate cancer on routine diagnostic biopsy: Sextant vs extended. BJU Int 2010;105(8):1089-1092
  • DOI: 10.1111/j.1464-410X.2009.08904.x
  • Nogueira L, Wang L, Fine SW, Pinochet R, Kurta JM, Katz D, et al. Focal Treatment or Observation of Prostate Cancer: Pretreatment Accuracy of Transrectal Ultrasound Biopsy and T2-weighted MRI. Urology 2010;75(2):472-477
  • DOI: 10.1016/j.urology.2009.04.061
  • Thong AE, Shikanov S, Katz MH, Gofrit ON, Eggener S, Zagaja GP, et al. A Single Microfocus (5% or Less) of Gleason 6 Prostate Cancer at Biopsy-Can We Predict Adverse Pathological Outcomes? J Urol 2008;180(6):2436-2440
  • DOI: 10.1016/j.juro.2008.08.027
  • Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD. Pathological Upgrading and Up Staging With Immediate Repeat Biopsy in Patients Eligible for Active Surveillance. J Urol 2008;180(5):1964-1968
  • DOI: 10.1016/j.juro.2008.07.051
  • Eastham JA, Riedel E, Scardino PT, Shike M, Fleisher M, Schatzkin A, et al. Variation of Serum Prostate-Specific Antigen Levels: An Evaluation of Year-to-Year Fluctuations. J Am Med Assoc. 2003;289(20):2695
  • DOI: 10.1001/jama.289.20.2695
  • Muller BG, Futterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, et al. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: Recommendations from a consensus panel. BJU Int 2014;289(20):2695
  • DOI: 10.1111/bju.12243
  • Villers A, Flamand V, Arquimedes RC, Puech P, Haber GP, Desai MM, et al. Robot-assisted partial prostatectomy for anterior prostate cancer: a step-by-step guide. BJU Int 2017;119(6):968-974
  • DOI: 10.1111/bju.13785
  • Villers A, Puech P, Flamand V, Haber GP, Desai MM, Crouzet S, et al. Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes. Eur Urol 2017;72(3):333-342
  • DOI: 10.1016/j.eururo.2016.08.057
  • Kaouk JH, Sagalovich D, Garisto J. Robot-assisted transvesical partial prostatectomy using a purpose-built single-port robotic system. BJU Int 2018;122:520-524
  • DOI: 10.1111/bju.14194
  • Silberstein JL, Power NE, Touijer KA. Laparoendoscopic single site (LESS) radical prostatectomy: A review of the initial experience. Minerva Urol Nefrol 2011; 63(2):123-9. PMID: 21623330.
  • Autorino R, Brandao LF, Sankari B, Zargar H, Laydner H, Akpa O, et al. Laparoen-doscopic single-site (LESS) vs laparoscopic living-donor nephrectomy: A systematic review and meta-analysis. BJU Int 2015;115(2):206-215
  • DOI: 10.1111/bju.12724
  • Park JY, Kim DY, Suh DS, Kim JH, Nam JH. Laparoendoscopic single-site versus conventional laparoscopic surgical staging for early-stage endometrial cancer. Int J Gynecol Cancer 2014.24(2):358-363
  • DOI: 10.1097/IGC.0000000000000046
  • Lee JY, Ha US, Lee SW. Initial experience of laparoendoscopic single-site radical prostatectomy requiring well-equipped appliances and a skilled technique. Case Rep Oncol 2010;3(3):445-450
  • DOI: 10.1159/000322818
  • Su J, Zhu Q, Yuan L, Zhang Y, Zhang Q, Wei Y. Transumbilical laparoendoscopic single-site radical prostatectomy and cystectomy with the aid of a transurethral port: a feasibility study. BJU Int 2018;121(1):111-118
  • DOI: 10.1111/bju.13965
  • Abdul-Muhsin HM, Jakob NJ, Kawashima A, Silva AC, Stanton ML, Moshero G, et al. Natural Orifice Transluminal Endoscopic Partial Prostatectomy: A Real-time Image-guided Focal Extirpative Feasibility Study. Urology 2017; 107:262-266.
  • DOI: 10.1016/j.urology.2017.05.024
  • Suardi N, Scattoni V, Briganti A, Salonia A, Naspro R, Gallina A, et al. Nerve-Sparing Radical Retropubic Prostatectomy in Patients Previously Submitted to Holmium Laser Enucleation of the Prostate for Bladder Outlet Obstruction Due to Benign Prostatic Enlargement. Eur Urol 2008;53(6):1180-1185
  • DOI: 10.1016/j.eu-ruro.2007.07.027
  • Gellhaus PT, Monn MF, Leese J, Flack CK, Lingeman JE, Koch MO, et al. Robot-Assisted Radical Prostatectomy in Patients with a History of Holmium Laser Enucleation of the Prostate: Feasibility and Evaluation of Initial Outcomes. J En-dourol 2015;29(7):764-769
  • DOI: 10.1089/end.2014.0767
  • Humphreys MR, Krambeck AE, Andrews PE, Castle EP, Lingeman JE. Natural orifice translumenal endoscopic surgical radical prostatectomy: Proof of concept. J Endourol 2009;23(4):669-675
  • DOI: 10.1089/end.2008.0670
  • Nagele U, Anastasiadis AG, Walcher U, Nicklas AP, Merseburger AS, Herrmann TR. Natural orifice (NOTES) transurethral sutureless radical prostatectomy with thulium laser support: First patient report. World J Urol 2012;30(5):625-631
  • DOI: 10.1007/s00345-011-0714-z
Еще
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp